[ORGANIZATION]
EMS
Featured in 5 tracked stories · first seen
Situations
Semaglutide regulatory approvals and pricing in Brazil
4 clusters · 79 sources · last updated
Latest: Anvisa approves second generic semaglutide in Brazil
Brazil’s National Health Surveillance Agency (Anvisa) has expanded the domestic market for semaglutide, a medication used to treat type 2 diabetes and weight loss. Initially, Anvisa registered five new semaglutide inject
Expansion of semaglutide generic and biosimilar markets
2 clusters · 12 sources · last updated
Latest: Sandoz targets biosimilar growth and generic semaglutide expansion
The pharmaceutical market for semaglutide-based medications is expanding through the introduction of generic and biosimilar alternatives. In Brazil, the National Health Surveillance Agency (Anvisa) approved new injectabl
Brazil trade diversification and strategic sovereignty
9 clusters · 105 sources · last updated
Latest: Brazil targets ASEAN trade growth to offset US tariff impacts
Brazil is advancing a dual strategy of trade diversification and healthcare modernization to bolster national sovereignty. To mitigate the impact of United States tariffs, which Minister Márcio Elias Rosa has labeled ‘il
Also covered in
-
PASI launches Medicamento Garantido to assist Brazilian families with medication costs
[HEALTH] · 2 sources ·